Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT
Launched by XIN LOU · Sep 6, 2024
Trial Information
Current as of November 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how artificial intelligence (AI) can help doctors diagnose problems with the blood vessels in the lungs using CT scans. Specifically, it's looking at patients who have chest pain, lung cancer, or suspected blood clots in the lungs (pulmonary embolism). The study aims to improve the quality of images taken without needing to inject a special dye, making it easier to detect issues with the pulmonary blood vessels. The researchers will use advanced AI techniques to analyze these images and assist healthcare providers in making more accurate diagnoses.
To participate in the trial, individuals must be between 18 and 100 years old and have had CT scans related to their lung condition. However, people with certain health issues, such as severe heart problems or specific aortic conditions, may not be eligible. If someone qualifies and joins the study, they can expect to undergo CT imaging that includes both standard scans and specialized pulmonary scans, which will be analyzed by AI to improve diagnosis accuracy. Overall, this trial aims to enhance the way lung vascular diseases are diagnosed, potentially leading to better treatment outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18≤100 years old Scan the pulmonary artery and its major branches Patients with suspected pulmonary embolism who received CTPA had a set of CTPA and CT scans The image quality meets the requirements of diagnosis and post-processing Patients who completed the examination in accordance with the data collection criteria Clinical data and follow-up were complete
- Exclusion Criteria:
- • Age \<18 years or age \>100 years The image is incomplete or incorrect Pulmonary artery absent or underenhanced Severe motion artifacts or image noise affect evaluation of pulmonary embolism History of aortic reconstruction, replacement, or stent implantation Congenital variations in the whole or important branches of the aorta in adults (e.g. bovine aortic arch, abnormal right subclavian artery) Severe hypovolemia and hemodynamic instability Severe heart failure with low ejection fraction Dialysis patient
About Xin Lou
Xin Lou is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong emphasis on ethical practices and patient safety, Xin Lou collaborates with leading healthcare professionals and institutions to conduct rigorous clinical studies across various therapeutic areas. The organization is focused on developing novel treatments and improving patient outcomes by leveraging cutting-edge technologies and methodologies. Xin Lou's commitment to transparency and collaboration ensures that its trials contribute valuable insights to the medical community and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Xin Lou
Study Chair
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported